Bill Linder Named New CEO

Bill Linder, HealthTronics CEO

HealthTronics has named Bill Linder its new Chief Executive Officer.

Linder was formerly President of Development for Surgical Care Affiliates (SCA), a leader in outpatient surgical care with more than 230 ambulatory surgery centers across the U.S. At SCA, he held several senior operational and business development roles within executive leadership. In 2017 and 2016, he was named a Rising Star in Healthcare by Becker’s Hospital Review and Becker’s ASC Review. Prior to joining SCA, Linder held sales leadership roles with Harden Healthcare and Apria Healthcare.

“HealthTronics has established itself as a top provider of specialized mobile medical therapies and highly trained personnel to physicians and health systems who utilize these solutions throughout the U.S.,” Linder said. “I look forward to working with my teammates to make HealthTronics a premier partner for the mobile medical therapies we provide and an employment destination for top talent.”

Linder said his focus going forward includes strengthening HealthTronics’ partnerships with independent medical groups and health systems, enhancing our patient experience through superior clinical quality and expanding into new markets.

“In this time of COVID-19, it is particularly important that our mobile solutions are helping healthcare systems and physicians deliver specialized care in optimized settings in a cost-effective manner,” said Linder.

HealthTronics’ customers include healthcare systems, surgery centers and other medical groups looking for efficient ways to add sophisticated medical equipment while lowering their capital expenditures. HealthTronics mobile medical technology offering includes lithotripsy, lasers, ultrasound, and cryoablation systems which are maintained and managed by HealthTronics, allowing physicians and other medical providers to focus on what they do best.

Don’t Forget Your PSA Test… Even During a Pandemic

Man getting a blood draw at physician’s office

September is Prostate Cancer Awareness Month

One in nine men will be diagnosed with prostate cancer during their lifetime, making it the most commonly diagnosed cancer among U.S. men, and one of the leading cancer killers among men, according to the Centers for Disease Control.

There are no early warning signs of prostate cancer, which can make it a potentially silent killer. In rare cases, prostate cancer can cause symptoms, so you should see your doctor if you experience any of the following:

  • A need to urinate frequently, especially at night, sometimes urgently
  • Difficulty starting or holding back urination
  • Weak, dribbling, or interrupted flow of urine
  • Painful or burning urination
  • Difficulty in having an erection
  • A decrease in the amount of fluid ejaculated
  • Painful ejaculation
  • Blood in the urine or semen
  • Pressure or pain in the rectum
  • Pain or stiffness in the lower back, hips, pelvis, or thighs

When Should You Get Screened

According to the US Preventative Services Task Force (USPSTF), if you have no family history and are not African American, you should start getting tested at age 50. Those with a family history should start getting screened at age 40. African American men should start at age 45.

Medical experts say the benefits of getting tested include early detection, which could offer you a better chance to cure the disease.

How do you screen for Prostate Cancer?

Two tests that are commonly used to screen for prostate cancer include:

  • A blood test called aprostate specific antigen (PSA) test. PSA is a substance your prostate makes. This test measures the level of PSA in your blood. Your PSA level may be high if you have prostate cancer and for many other reasons, such as having an enlarged prostate, a prostate infection, or taking certain medicines.
  • Digital rectal examination, when a health care provider inserts a gloved, lubricated finger into a man’s rectum to feel the prostate for anything abnormal, such as cancer.

How Do You Treat Prostate Cancer?

Your doctor can discuss the best treatment option for you. Fortunately, there are many effective ways to address prostate cancer. According to the American Cancer Society, here are the current treatment options:

  • Observation or Active Surveillance
  • Surgery
  • Radiation Therapy
  • Cryotherapy
  • Hormone Therapy
  • Chemotherapy
  • Immunotherapy
  • Targeted Therapy

HealthTronics partners with hundreds of urologists across the country with their innovative cryotherapy systems called Cryocare. Instead of being treated with strong medications or having to undergo multiple rounds of radiation, cryotherapy uses small ice crystals to kill the cancer cells.

Cryotherapy is not major surgery. Many patients that are too weak or ill to have a prostatectomy (prostate removal) and don’t want radiation therapy can still consider cryotherapy. If your cancer is localized to the prostate, you may be a good candidate for cryotherapy. Ask your urologist if cryotherapy is right for your cancer treatment.

Treating Summertime Kidney Stones with Mobile Lithotripsy

Much of the country is experiencing a massive heat wave, including many areas with triple digit temperatures. This means high humidity, which can lead to dehydration for many people. Drinking plenty of water can help reduce your risk of heat stroke and dehydration. But it can also lower your risk of developing painful kidney stones. The Cleveland Clinic finds more people go to the doctor with kidney stones during the summer months than any other time of the year.

Kidney stones form when certain chemicals like calcium, oxalates and phosphorous form crystals that grow into stones and block the flow of urine. They can be incredibly painful and downright dangerous. They can vary in size from a grain of sand to more than an inch in diameter. They build up gradually, and can be found anywhere in the urinary tract.

Drinking soda, especially dark colored colas, can significantly increase your risk of stone formation.  If left untreated, kidney stones can block the ureter and make it narrower, which increases the risk of infection and added strain on the kidneys.

Fortunately, there are many effective treatments for kidney stones, including Extracorporeal Shockwave Lithotripsy. Lithotripsy is a simple and noninvasive procedure where your urologist uses sound waves to break down the stones so they can pass naturally. Using x-ray or ultrasound, physicians target the stone and use multiple high-energy pressure waves until it breaks into tiny particles. This helps them pass naturally from the urinary system.

While lithotripsy is a routine procedure, the equipment your physician uses is extremely important. HealthTronics provides the mobile equipment to your urologist and ensures that these sophisticated and high-tech devices are maintained according to industry standards. Physicians do more than 50,000 lithotripsy procedures every year with our equipment. Our lithotripsy technologists, who have an average of 12 years of experience, work side by side with physicians during every procedure.

HealthTronics Responds to COVID-19 Pandemic

Coronavirus Covid-19 cell. Covid, covid19 pandemic.

Our hearts and thoughts go out to all our customers – the healthcare workers at the front line serving the communities across the nation during this unprecedented health crisis. We are grateful for the relationships we’ve built with you and remain dedicated to serving your facility, and its patients, in any way we can.

As the Coronavirus (COVID-19) continues to be the top priority we’ve been actively monitoring updates from the CDC and have taken several steps to sustain our services:

We are taking our cue from the CDC and our Customers
HealthTronics is following the most recent CDC guidance including hygiene practices, eliminating non-critical travel, eliminating face to face meetings, and requiring a 14-day quarantine for any employee who is not feeling well, is exhibiting symptoms of COVID-19, or who has been in contact with someone thought to have been exposed to the COVID-19 virus.


✓ Our Field and Clinical staff are following all procedures implemented by the healthcare facilities we serve including temperature screening prior to entering the facility.

✓ Our Scheduling staff remains available should our customers need to reschedule certain procedures.

✓ Our Contracting staff are monitoring our customers’ contracts and taking the necessary steps to ensure service is uninterrupted should your facility’s contract expire and helping to put in place short-term interim arrangements to cover any mobile services you may source through another vendor that is currently unable to meet your requirements.

✓ Our Sales Support staff continues to field inquiries from our customers and are working with our Territory Sales Managers and the Operations Team to monitor changes in customer demand to ensure the resources shift to accommodate these changes.

We have implemented enhanced equipment cleaning procedures
Our Field and Clinical Staff have implemented enhanced sterilization procedures. In addition to normal pre and post-procedure sterilization, our mobile staff are required to clean and disinfect all equipment including C-arms, Lithotripters, Lasers, Ultrasounds, Cryotherapy and all transport vehicles at the beginning and end of each workday. In addition, any field/clinical staff receiving inventory shipments must clean the packaging with disinfectants and wash their hands after handling shipments.

We remain at the ready
HealthTronics understands that its employees – the many tenured, skilled staff of technicians, clinicians, and support staff – are fundamental to our ability to be ready today and ready when the health crisis is over to serve our customers and we have taken the first steps to keep our staff actively employed. We stand committed to continuing to provide mobile services to the best of our ability during this challenging time.

What we ask of you is to keep us informed. Let us know what we can do to help and support you in your efforts to support the patients you serve.


We are vigilantly monitoring the COVID-19 situation and will continue to implement the necessary precautionary measures to ensure the safety of our customers, employees, and the communities we serve.

If you have any questions or want to share information with us, please contact our Sales Support Team at salessupport@healthtronics.com

Technologists Support the Treatment of Prostate Cancer

When urologist Eric Giesler, MD opted to use the Endocare® Cryocare® cryotherapy system to treat his patients’ prostate cancer, he had two vendor choices “and this, in my opinion, is the better one.”

Also better: the technologist support he gets when he uses the system to treat about 30 patients annually at four Austin-area hospitals.

“HealthTronics technologists are pretty important,” said Dr. Giesler, a Urology Austin general provider with a focus on urologic oncology. “They’re looking out for any potential missteps. If you forget something, they’re invaluable as a secondary check.”

A technologist shows up at the hospital with the cryotherapy system under arrangements Dr. Giesler has with HealthTronics. It’s a helpful, extra convenience to go along with Endocare® cryotherapy’s “versatile technology that allows you to treat prostate cancer very precisely,” Dr. Geisler said.

He has built a proven record of success utilizing the system since 2014 – to the point where colleagues in the 42-provider Urology Austin group regularly refer their patients to him for “freezing” prostate tumors. The process is natural, nontoxic and low-impact for high-risk and weaker patients not suited for surgery or radiation therapy.

It also can be used for “salvage cryotherapy,” which is effective in the 20-30 percent of patients where radiation is ineffective. This Endocare® system also is being used more commonly for interventional oncology treatment of cancer cells in lungs and kidneys, as well as on liver metastases and in palliative interventions (including managing pain from metastatic cancer).

Mobile Medical Technology at AUA in San Francisco May 18-21

The Golden Gate Bridge in San Francisco with beautiful blue ocea

The American Urological Association (AUA) stands at the forefront of developing innovative, evidence-based urologic education for urologists and urologic health care professionals worldwide. This year’s annual meeting includes several presentations regarding technologies that HealthTronics provides on a mobile basis.

Presentations include:

ESWL: Fewer Days Off Work and Fewer ER Visits

  • Patients treated with ESWL required only 3 days off work. URS patients required almost 8 (read abstract).
  • Only 7.5% went to the ER within 30 days compared to 10.6% for URS and 13.2% for PCNL (read abstract).

Cryoablation: Incontinence and ADT Minimal

  • Only 16.5% of primary whole-gland prostate cryoablation patients had urinary incontinence after 0-9 months and 3.6% after 10-12 months (read abstract).
  • After 12 months follow-up, 80% of salvage prostate cryoablation patients remained ADT-free (read abstract).

PVP: Continues to Demonstrate Good Results

  • At 5 years, PSA, IPSS, QoL, and PVR dropped by 59.7%, 75.2%, 78.72%, and 84.4%, respectively (read abstract).
  • Antegrade ejaculation was preserved in 90.7% of patients at 1-3 months and this rate remained constant until 24-36 months (read abstract).

Russell Newman in Texas CEO Magazine

HealthTronics president, Russell Newman penned a contributed article titled, ‘A Company’s Most Valued Assets: Customer-Facing Employees’. The important message from Newman: Frontline employees are the agents driving change. Their message to the customers is to “trust me because I can make this easier for you.” And so, if an executive wants to make change easy for customers, he or she needs to make things easy – or at least as easy as possible – for the company’s most valued assets: its customer-facing employees.

You can read the entire article here.

Acquisition of Mobile Medical Marketing Covered in Austin Business Journal

HealthTronics, Inc., a mobile medical technology company has acquired mobile laser technology company, Mobile Medical Marketing, LLC (Mobile Medical), based in Albuquerque, New Mexico.

“With this acquisition, we’re delivering on our strategy to become the first choice for our customers when seeking laser treatments and other mobile medical technology applications,” explained Russell Newman, president of HealthTronics.

Mobile Medical provides various laser therapies for ENT, neurology and ob-gyn procedures to hospital systems, surgery centers and physician offices in Albuquerque. The acquisition expands HealthTronics’ fleet of mobilized medical technology and strengthens its reach into other areas of the U.S., including New Mexico.

Earlier this year, HealthTronics acquired United Therapies, a provider of mobile lithotripsy and laser technology to healthcare providers in the Midwest, Northeast and Southwest regions of the United States.

“Rising healthcare costs have made mobile medical technology an attractive option for reducing costs among hospitals and surgical centers. By utilizing mobile equipment, providers can have access to new technology and treatments when they otherwise could not afford the costs associated with purchasing and maintaining the equipment,” said Newman.

HealthTronics’ technology is “mobile” because the company delivers the medical device to the health care facility where the physician conducts each procedure. In addition to servicing and updating the equipment, each delivery includes a dedicated, highly trained HealthTronics’ technologist to assist with the operation of the equipment.

Click here to read the Austin Business Journal story.

HealthTronics Signs Agreement with HealthTrust

AUSTIN, Texas – (June 27, 2016) –HealthTronics Mobile Solutions, LLC, a subsidiary of HealthTronics, Inc.,  has entered into a supplier agreement with Brentwood, Tennessee-based HealthTrust.

The move will give HealthTrust members across the country access to HealthTronics’ cutting-edge, minimally invasive mobile medical technology, including lasers, ultrasound, cryoablation and microwave ablation systems. HealthTronics’ mobile medical therapies are used to treat conditions such as cancerous tumors and kidney stones.

Russell Newman, President of HealthTronics, said, “In an environment where cost pressures may be a significant concern, we strive to increase choices for healthcare providers and their patients. We’re excited to have the opportunity to serve as a HealthTrust supplier.”

About HealthTronics:

HealthTronics, Inc., established in 1989 and headquartered in Austin, Texas, provides integrated, mobilized medical technologies and services, as well as physician partnership opportunities. The company brings its advanced technology and support systems to health care providers throughout the United States.  For more information visit healthtronics.com.

About HealthTrust:

HealthTrust (Healthtrust Purchasing Group, L.P.) is committed to strengthening provider performance and clinical excellence through an aligned membership model and the delivery of total spend management solutions, including supply chain solutions and a contract and service portfolio unparalleled in quality, scope and value. HealthTrust (www.healthtrustpg.com) serves over 1,400 acute care facilities and members in more than 22,600 other locations, including ambulatory surgery centers, physician practices, long-term care and alternate care sites. Headquartered in Brentwood, Tennessee, HealthTrust is affiliated with Parallon Business Solutions, LLC (www.parallon.com), a leading provider of healthcare business and operational services, including revenue cycle management, workforce and technology solutions. On Twitter @healthtrustpg and @parallonconnect.

HealthTronics Expands Mobile Medical Technology Portfolio

Austin, Texas – March 9, 2016 – Mobile medical technology company HealthTronics, Inc.,  a portfolio company of Altaris Capital Partners, LLC, announced it has acquired Chicago-based United Therapies, LLC. The move not only expands HealthTronics’ fleet of mobilized medical technology, it broadens the Austin-based company’s reach across the United States and includes investments in facilities that provide low-cost alternatives to hospitals.

Founded in 1985, United Therapies provides mobile lithotripsy and laser technology to healthcare providers in Colorado, Connecticut, Illinois, Indiana, Iowa, Maine, Massachusetts, Michigan, Minnesota, Missouri, Montana, New Mexico, New York, Oklahoma, Oregon, Pennsylvania, Rhode Island, Texas, Virginia, Washington, West Virginia and Wisconsin.

The acquisition of United Therapies brings HealthTronics’ total number of employees to over 550 nationwide.

“Continuing to build our portfolio underscores our mission to provide exceptional and effective technologies that improve patient care across a spectrum of medical specialties including urology, interventional radiology, otolaryngology (ENT), aesthetics, gynecology, neurology, orthopedics, podiatry and vascular,” said Russell Newman, President of HealthTronics.

He also said, “Expanding our geographic reach offers more specialists and other healthcare providers easier access to HealthTronics’ applications, which include lithotripsy, microwave ablation, nerve monitoring, laser treatment and cryotherapy for urology and interventional radiology.”

HealthTronics delivers mobile devices to medical facilities, where a physician conducts each procedure. A dedicated, highly trained HealthTronics technologist assists with operation of the equipment.

This process gives healthcare providers access to the latest technology and cutting edge treatments when they otherwise could not afford the costs associated with purchasing and maintaining the equipment, replacing technology when it becomes obsolete, and training support staff.

“HealthTronics’ mobile medical technology enables doctors and hospitals of any size – from comprehensive medical centers to offices in remote, rural communities — to provide a wider array of clinical treatment options,” said Newman. “Expanding our geographic reach and investing in alternative treatment facilities through the acquisition of United Therapies will help us put the best tools available into the hands of even more physicians.”

Austin Urologist Discusses Cryotherapy and Prostate Cancer Awareness Month with KTBC-TV

September is Prostate Cancer Awareness month, a time when the disease is brought into focus.

Dr. Eric Giesler, a urologist in Austin, Texas, talked about cryotherapy for recurrent prostate cancer with local Fox affiliate, KTBC.

Dr. Giesler’s patient and local pastor, Rick Cundieff, shared his prostate cancer journey and his positive experience with cryotherapy. Cundieff had the treatment twice — the first time in 2005, and then again this year when the cancer struck again.

Both Cundieff and Dr. Giesler urged men to start the conversation about prostate cancer, the PSA screening test, and treatment options, should a problem arise.

HealthTronics Acquires Management Company, Expands Mobile Lithotripsy Solutions

AUSTIN, TX (PRWEB) JULY 31, 2015 HealthTronics, Inc., an Austin, Texas-based mobile medical services and medical devices company, has expanded its mobile portfolio with the acquisition of the management company for two lithotripsy service companies, Carolina Lithotripsy and Advanced Urotech.

Lithotripsy, a minimally invasive procedure for treating kidney stones, uses shock waves to break the stone into small particles to allow the body to more easily pass it out.

Carolina Lithotripsy has provided lithotripsy services in North Carolina since 1984 and Advanced Urotech in Southern California since 1997. The two entities will now be managed by HealthTronics, adding more than 80 physician partners and about 20 employees under the HealthTronics umbrella.

“With this acquisition, doctors and hospitals in these areas – whether rural community hospitals or comprehensive medical centers – will have access to HealthTronics’ clinical expertise and diverse mobile medical portfolio,” said Russell Newman, President of HealthTronics.

In addition to lithotripsy, HealthTronics offers technology for microwave ablation, nerve monitoring, laser treatment and cryotherapy. As a mobile services provider, HealthTronics delivers the mobile device to the medical facility where the physician conducts the procedure. A dedicated, highly trained HealthTronics technician remains onsite for equipment operation needs, and experienced ancillary staff prevent any interruption in service.

Since becoming an independent company in February 2014, HealthTronics has completed six distribution and/or acquisition transactions, positioning HealthTronics as one of the top mobile solutions providers in the United States.

About HealthTronics
HealthTronics, Inc., founded in 1989 and headquartered in Austin, Texas, provides minimally invasive, mobile medical therapies for clinically sophisticated applications such as urological and interventional radiology indications. The company brings its advanced technology and support systems to healthcare providers across the United States. HealthTronics’ solutions include lithotripsy services, laser and cryotherapy equipment rentals, maintenance services and physician partnership opportunities.

HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors

Austin, Texas (PRWEB) May 27, 2015 In today’s healthcare landscape, where costs are growing and margins are getting tighter, it can be challenging for doctors and hospitals to keep up with the latest technology for cutting edge treatments.

Austin-based HealthTronics, Inc. is offering a solution to that problem, with minimally invasive, mobile medical therapies for clinically sophisticated applications. The company has now broadened its mobile medical portfolio with the acquisition of Laser Ventures, Inc., a mobile laser technology company based in Woodstock, Georgia. The company’s lasers are used for a wide variety of procedures, including urology, orthopedics, gynecology, neurology and many other indications.

“By mobilizing more technology, we can effectively and efficiently accommodate the needs of any size health care provider, from comprehensive medical centers to remote and rural communities,” explained Russell Newman, president of HealthTronics.

For over 25 years, HealthTronics has focused on providing mobile medical technology for urology indications. Since becoming an independent company in February 2014, HealthTronics has been acquiring companies and technologies to serve more specialists, including interventional radiologists and oncologists.

Newman says medical providers and healthcare facilities benefit from mobile technology because there is no large capital payment required, there is little to no risk of the device becoming obsolete, and there are no administrative headaches of maintaining the technology or training support staff to help operate it.

HealthTronics’ mobile medical technologies allow doctors and hospitals to access a device for individual procedures so that they can provide a wide array of clinical treatment options without purchasing and servicing big pieces of equipment. Current applications include lithotripsy, microwave ablation, nerve monitoring, laser treatment and cryotherapy for urology and interventional radiology.

HealthTronics delivers the mobile device to the medical facility where the physician conducts the procedure. A dedicated, highly trained HealthTronics technologist assists with operation of the equipment, and studies show that experienced technologists can directly impact the overall treatment success rates.1

HealthTronics is able to accommodate any size healthcare provider, from comprehensive medical centers to those in remote and rural communities.

Said Newman, “HealthTronics’ mobile health solutions can be used for treating cancerous tumors to breaking up kidney stones to nerve monitoring during delicate prostate cancer surgeries. And we’ll continue to listen to physicians and health industry experts to expand our minimally invasive treatment options moving forward.”

About HealthTronics
HealthTronics, Inc., established in 1989 and headquartered in Austin, Texas, provides integrated urological and interventional radiology products and services, as well as physician partnership opportunities. The company brings its advanced technology and support systems to health care providers throughout the United States. For more information visit healthtronics.com.

About Laser Ventures
Laser Ventures, Inc. mobile laser solutions serves facilities throughout the Southeast. It provides highly trained technologists, state of the art mobile medical lasers and uncompromising customer service. In addition, it buys and sells lasers and accessories to customers all over the world. For more information visit laserventures.com.

The HT HEALTHTRONICS logo is a trademark of HealthTronics, Inc.

1. Lee C et al: Impact of Learning Curve on Efficacy of Shockwave Lithotripsy. Radiologic Technology September/October 2008, Vol. 80/No. 1: pp. 20-24.

HealthTronics Announces Distribution Agreement with Clinicon

AUSTIN, Texas – (September 20, 2014) HealthTronics, Inc., a leading provider of integrated urological and interventional radiology products and services, has signed a distribution agreement through its Endocare, Inc. subsidiary with Clinicon Corporation for its high precision laser technology.  The addition expands HealthTronics’ portfolio of minimally invasive, mobile, surgical technology—offering more choices for healthcare providers and their patients.

Under the agreement, HealthTronics will make available Clinicon’s FDA-cleared SureLase™ CO2 Laser System and Fiber Accessories to physicians, hospitals, surgical centers and other health care providers for a wide range of surgical specialties.

HealthTronics and Clinicon will jointly exhibit at the AAO-HNSF 2014 in Orlando to address the ENT (Ear, Nose, and Throat) market. Some of the most common ENT surgeries performed with the SureLase™ CO2 Laser System include micro laryngoscopies, bronchoscopies, and stapedectomies.

“Clinicon’s high precision laser technology replaces bulky articulating mirror arms with thin fiber optics to reduce trauma to patients during laser surgical procedures. This makes it a natural complement to our portfolio of minimally invasive mobile products,” said Russell Newman, President of HealthTronics.

Clinicon’s surgical tools are used to deliver CO2 laser energy for incision, ablation and coagulation or cauterization of soft tissue. The CO2 laser, often known as the original “surgical laser,” most resembles the traditional surgical instruments for cutting, ablation and coagulation.

Since becoming an independent company in February 2014, HealthTronics has pursued a strategy to expand its portfolio of minimally invasive mobile technology. Said Newman, “With mobile technology, health care providers can offer more comprehensive care efficiently and effectively by not taking on large capital costs and maintenance. That’s an advantage for the provider and the patient.”

To date, HealthTronics has added nerve monitoring equipment for use during robotic prostate surgery and targeted microwave energy for ablation of soft tissues. Other technologies currently offered by the company include Endocare® cryotherapy systems for ablation of prostate, kidney and lung cancer tumors, lithotripters for fragmenting kidney stones and lasers for treating benign prostate hyperplasia (BPH).
About HealthTronics

HealthTronics, Inc., established in 1989 and headquartered in Austin, Texas, provides integrated urological and interventional radiology products and services, as well as physician partnership opportunities. The company brings its advanced technology and support systems to health care providers throughout the United States. For more information visit www.healthtronics.com.

About Clinicon

Clinicon Corporation, a medical device company headquartered in Oceanside, California, has pioneered the technology for next-generation, minimally invasive surgical laser devices for over 17 years. Clinicon’s PureBeam™ delivery system utilizes fiber optics to improve surgical precision and visual control over traditional lasers, while minimizing trauma to patients. Clinical efficacy and low costs make the product line commensurate with the Gold Standard Tests and Reduced Cost Requirements of the Affordable Care Act. Clinicon’s products are used in more than 200 hospitals in the US and overseas.  For more information visit www.clinicon.com.

ENDOCARE is a trademark of Endocare, Inc., registered in the U.S. with the U.S. Patent and Trademark Office and in other countries.  The HT HEALTHTRONICS logo is a trademark of HealthTronics, Inc.  CLINICON logo, PRECISION FOCUSED, SURELASE and PUREBEAM are trademarks of Clinicon Corporation.

HealthTronics Acquires Three Mobile Lithotripsy Companies

AUSTIN, Texas – (August 15, 2014) – HealthTronics, Inc. has acquired three mobile lithotripsy service companies, Baltimore Lithotripsy Associates (BLA), American Mobile Advantage and American Mobile Advantage CA (collectively AMA), thereby expanding its fleet of mobilized technology for urological care.

BLA and AMA have been providing lithotripsy services in and around the Mid-Atlantic region, Northern California and the state of Washington for over a dozen years.

“The acquisitions underscore our mission to provide exceptional and effective technologies that improve patient care,” said Russell Newman, President of HealthTronics. “Health care providers will have easier access to lithotripsy technology as well as HealthTronics’ broad portfolio of interventional radiology and urology solutions.”
Newman said the acquisition strengthens HealthTronics relationship with the regions’ hospitals and large urology group practices, and also complements the company’s strategic goal—to support and grow its core mobile technology and services business. “By mobilizing more technology, we can effectively and efficiently accommodate the needs of any size health care provider, from comprehensive medical centers to remote and rural communities.”

Lithotripsy, a noninvasive procedure for treating kidney stones, uses shock waves to break the stone into small particles to allow the body to more easily pass it out. Kidney stones are one of the most common disorders of the urinary tract. According to the National Kidney Foundation®, one in ten people in the United States will have a kidney stone during their lifetime and over half a million people a year go to the emergency room for treatment (http://www.kidney.org/atoz/content/kidneystones.cfm).

Since divesting from Endo International plc in February 2014, HealthTronics has focused on expanding its portfolio of products and services, including seeking FDA clearance for additional therapeutic applications of its existing cryotherapy technology.

Other technologies offered by HealthTronics include Endocare® cryotherapy systems for ablation of prostate, kidney and lung cancer tumors, lasers for treating benign prostatic hyperplasia (BPH), microwave ablation systems for treating soft tissue and nerve monitoring equipment for use during robotic prostate surgery.

About HealthTronics

HealthTronics, Inc., established in 1989 and headquartered in Austin, Texas, provides integrated urological and interventional radiology products and services, as well as physician partnership opportunities. The company brings its advanced technology and support systems to health care providers across the United States.  For more information visit www.healthtronics.com.

ENDOCARE is a trademark of Endocare, Inc., registered in the U.S. with the U.S. Patent and Trademark Office and in other countries.  The HT HEALTHTRONICS logo is a trademark of HealthTronics, Inc.  The NATIONAL KIDNEY FOUNDATION is a registered trademark of the National Kidney Foundation, Inc.

http://www.prweb.com/releases/2014/08/prweb12093965.htm

Endo Completes Divestiture Of HealthTronics

MALVERN, Pa., Feb. 3, 2014 /PRNewswire/ – Endo Health Solutions (Nasdaq: ENDP) today announced that it has completed the previously announced divestiture of HealthTronics to Altaris Capital Partners, LLC for an upfront cash payment of $85 million, subject to cash and other working capital adjustments.  In addition, Endo received rights to additional cash payments of up to $45 million based on the future operating performance of HealthTronics for a total consideration of up to $130 million.

The closing of this transaction and the earlier announced sales of HealthTronics’ anatomical pathology business and IGRT business completes Endo’s full divestiture of all HealthTronics businesses.

About Endo
Endo Health Solutions Inc. is a U.S.-based specialty healthcare company with business segments that are focused on branded pharmaceuticals, generics, and medical devices which deliver quality products to its customers intended to improve the lives of patients. Through its operating companies – Endo Pharmaceuticals, Qualitest, and AMS – Endo is dedicated to delivering value to our stakeholders:  customers, patients, and shareholders. Learn more at www.endo.com.

About Altaris Capital Partners
Altaris is an investment firm focused exclusively on the healthcare industry.  With over $1.3 billion of equity capital under management, Altaris invests in businesses that meet clearly defined healthcare needs.  Altaris’ portfolio companies are typically headquartered in North America or Western Europe, but have operations throughout the world.  Altaris is based in New York.  For more information, please visit www.altariscap.com.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements including words such as “believes,” “expects,” “anticipates,” “intends,” “estimates,” “plan,” “will,” “may,” “look forward,” “intend,” “guidance,” “future” or similar expressions are forward-looking statements. Because these statements reflect our current views, expectations and beliefs concerning future events, these forward-looking statements involve risks and uncertainties. Investors should note that many factors, as more fully described under the caption “Risk Factors” in Endo’s Form 10-K, Form 10-Q and Form 8-K filings with the Securities and Exchange Commission and as otherwise enumerated herein or therein, could affect Endo’s future financial results and could cause Endo’s actual results to differ materially from those expressed in forward-looking statements contained in our Annual Report on Form 10-K. The forward-looking statements in this press release are qualified by these risk factors. These are factors that, individually or in the aggregate, could cause our actual results to differ materially from expected and historical results. Endo assumes no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.

SOURCE Endo Health Solutions Inc.

Investors/Media: Blaine Davis, (484) 216-7158; Investors: Jonathan Neely, (484) 216-6645; Media: Brian O’Donnell, (484) 216-6726

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding Endo Pharmaceuticals business which are not historical facts are “forward-looking statements” that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” in the Company’s Annual Report or Form 10-K for the most recently ended fiscal year.